Literature DB >> 24428962

Stress triggers coronary mast cells leading to cardiac events.

Michail Alevizos1, Anna Karagkouni2, Smaro Panagiotidou3, Magdalini Vasiadi3, Theoharis C Theoharides4.   

Abstract

OBJECTIVE: Stress precipitates and worsens not only asthma and atopic dermatitis but also acute coronary syndromes (ACSs), which are associated with coronary inflammation. Evidence linking stress to ACS was reviewed and indicated that activation of coronary mast cells (MCs) by stress, through corticotropin-releasing hormone (CRH) and other neuropeptides, contributes to coronary inflammation and coronary artery disease. DATA SOURCES: PubMed was searched (2005-2013) for articles using the following keywords: allergies, anaphylaxis, anxiety, coronary arteries, coronary artery disease, C-reactive protein, cytokines, chymase, histamine, hypersensitivity, interleukin-6 (IL-6), inflammation, mast cells, myocardial ischemia, niacin, platelet-activating factor, rupture, spasm, statins, stress, treatment, tryptase, and uroctortin. STUDY SELECTIONS: Articles were selected based on their relevance to how stress affects ACS and how it activates coronary MCs, leading to coronary hypersensitivity, inflammation, and coronary artery disease.
RESULTS: Stress can precipitate allergies and ACS. Stress stimulates MCs through the activation of high-affinity surface receptors for CRH, leading to a CRH-dependent increase in serum IL-6. Moreover, neurotensin secreted with CRH from peripheral nerves augments the effect of CRH and stimulates cardiac MCs to release IL-6, which is elevated in ACS and is an independent risk factor for myocardial ischemia. MCs also secrete CRH and uroctortin, which induces IL-6 release from cardiomyocytes. The presence of atherosclerosis increases the risk of cardiac MC activation owing to the stimulatory effect of lipoproteins and adipocytokines. Conditions such as Kounis syndrome, mastocytosis, and myalgic encephalopathy/chronic fatigue syndrome are particularly prone to coronary hypersensitivity reactions.
CONCLUSION: Inhibition of cardiac MCs may be a novel treatment approach.
Copyright © 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24428962      PMCID: PMC4288814          DOI: 10.1016/j.anai.2013.09.017

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  186 in total

1.  Serum neurotensin (NT) is increased in psoriasis and NT induces vascular endothelial growth factor release from human mast cells.

Authors:  M Vasiadi; A Therianou; K D Alysandratos; A Katsarou-Katsari; T Petrakopoulou; A Theoharides; E Papadavid; N Stavrianeas; C Antoniou; D Kalogeromitros; T C Theoharides
Journal:  Br J Dermatol       Date:  2012-05-14       Impact factor: 9.302

Review 2.  Mast cells squeeze the heart and stretch the gird: their role in atherosclerosis and obesity.

Authors:  Theoharis C Theoharides; Nikolaos Sismanopoulos; Danae-Anastasia Delivanis; Bodi Zhang; Erifili E Hatziagelaki; Dimitrios Kalogeromitros
Journal:  Trends Pharmacol Sci       Date:  2011-07-07       Impact factor: 14.819

Review 3.  Stress and cardiovascular disease.

Authors:  Andrew Steptoe; Mika Kivimäki
Journal:  Nat Rev Cardiol       Date:  2012-04-03       Impact factor: 32.419

4.  Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease.

Authors:  Wei Jiang; Zainab Samad; Stephen Boyle; Richard C Becker; Redford Williams; Cynthia Kuhn; Thomas L Ortel; Joseph Rogers; Maragatha Kuchibhatla; Christopher O'Connor; Eric J Velazquez
Journal:  J Am Coll Cardiol       Date:  2013-02-19       Impact factor: 24.094

5.  Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice.

Authors:  Tatsuya Oka; Janet Kalesnikoff; Philipp Starkl; Mindy Tsai; Stephen J Galli
Journal:  Lab Invest       Date:  2012-08-20       Impact factor: 5.662

6.  Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin.

Authors:  Kristiana Kandere-Grzybowska; Duraisamy Kempuraj; Jing Cao; Curtis L Cetrulo; Theoharis C Theoharides
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

7.  The histologic and functional characterization of enzymatically dispersed intestinal mast cells of nonhuman primates: effects of secretagogues and anti-allergic drugs on histamine secretion.

Authors:  K E Barrett; D D Metcalfe
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

Review 8.  The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease.

Authors:  Marina O'Kane; Evelyn P Murphy; Brian Kirby
Journal:  Exp Dermatol       Date:  2006-03       Impact factor: 3.960

9.  Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery.

Authors:  P Laine; M Kaartinen; A Penttilä; P Panula; T Paavonen; P T Kovanen
Journal:  Circulation       Date:  1999-01-26       Impact factor: 29.690

10.  IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

Authors:  Theoharis C Theoharides; Bodi Zhang; Duraisamy Kempuraj; Michael Tagen; Magdalini Vasiadi; Asimenia Angelidou; Konstantinos-Dionysios Alysandratos; Dimitris Kalogeromitros; Shahrzad Asadi; Nikolaos Stavrianeas; Erika Peterson; Susan Leeman; Pio Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

View more
  15 in total

Review 1.  Mast Cell Activation Syndrome.

Authors:  Marianne Frieri
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 2.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

3.  Prolactin mediates effects of chronic psychological stress on induction of fibrofatty cells in the heart.

Authors:  Jiangping Song; Mangyuan Wang; Xiao Chen; Li Liu; Liang Chen; Zhizhao Song; Xiao Teng; Yong Xing; Kai Chen; Kun Zhao; Jianfeng Hou; Pingchang Yang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Gut Barrier Dysfunction and Type 2 Immunity: Implications for Compulsive Behavior.

Authors:  Christopher T Fields; Benoit Chassaing; Geert J de Vries
Journal:  Med Hypotheses       Date:  2022-02-14       Impact factor: 4.411

Review 5.  Mast cells in human and experimental cardiometabolic diseases.

Authors:  Guo-Ping Shi; Ilze Bot; Petri T Kovanen
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

6.  Increased Number of Mast Cells in Epicardial Adipose Tissue of Cardiac Surgery Patients With Coronary Artery Disease.

Authors:  K Rozsívalová; A Pierzynová; H Kratochvílová; J Lindner; M Lipš; T Kotulák; P Ivák; I Netuka; M Haluzík; T Kučera
Journal:  Physiol Res       Date:  2020-06-25       Impact factor: 1.881

Review 7.  Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin.

Authors:  Theoharis C Theoharides; Julia M Stewart; Erifili Hatziagelaki; Gerasimos Kolaitis
Journal:  Front Neurosci       Date:  2015-07-03       Impact factor: 4.677

8.  Aerobic Exercise-Assisted Cardiac Regeneration by Inhibiting Tryptase Release in Mast Cells after Myocardial Infarction.

Authors:  Mohammad Bayat; Sufan Chien; Farzaneh Chehelcheraghi
Journal:  Biomed Res Int       Date:  2021-06-08       Impact factor: 3.411

9.  Novel Roles for Kv7 Channels in Shaping Histamine-Induced Contractions and Bradykinin-Dependent Relaxations in Pig Coronary Arteries.

Authors:  Xingjuan Chen; Wennan Li; S Christopher Hiett; Alexander G Obukhov
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

10.  Asthma is associated with atherosclerotic artery changes.

Authors:  Izabela Tuleta; Dirk Skowasch; Florian Aurich; Nicolas Eckstein; Robert Schueler; Carmen Pizarro; Nadjib Schahab; Georg Nickenig; Christian Schaefer; Simon Pingel
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.